U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Edge D, Degnan A, Cotterill S, et al. Culturally adapted Family Intervention (CaFI) for African-Caribbean people diagnosed with schizophrenia and their families: a mixed-methods feasibility study of development, implementation and acceptability. Southampton (UK): NIHR Journals Library; 2018 Sep. (Health Services and Delivery Research, No. 6.32.)

Cover of Culturally adapted Family Intervention (CaFI) for African-Caribbean people diagnosed with schizophrenia and their families: a mixed-methods feasibility study of development, implementation and acceptability

Culturally adapted Family Intervention (CaFI) for African-Caribbean people diagnosed with schizophrenia and their families: a mixed-methods feasibility study of development, implementation and acceptability.

Show details

Appendix 2Characteristics of studies included in the systematic review of culturally adapted interventions (n = 46)

Author (year)Study arms (n)Sample characteristicStudy settingStudy designPatient outcome measures (time point)Attrition: time point, n (%)Key finding(s)
Adapted intervention(s)Comparison group(s)Gender, n (M/F)Mean age (years)Diagnosis (diagnostic tool)Chronicity/duration illness (years)
Bradley et al. (2006)115MFGT, 30Standard care – enhanced, 29Total, 50 (15/35); MFGT, 25 (7/18); CG, 25 (8/17)MFGT, 33.6; CG, 34DSM-IV; outpatient diagnosis schizophrenia by psychiatristHAs 12 months pre intervention: MFGT, 0.60; CG, 0.29Community mental health programme of the Inner West Mental Health Service Royal Melbourne Hospital and participant homeRCTBPRS; SANS; HoNOS; QOL (baseline, post intervention); relapse rates (post intervention, 18 months post intervention)18 months post intervention: total, 9/59 (15.3); MFGT, 5/30 (16.7); CG, 4/29 (13.8)

Significant reduction found between baseline and post-intervention BPRS symptom scores for MFGT but no difference for the CG

Relapse rates at end and 18 months post intervention were significantly lower for MFGT than for the CG

Carrà et al. (2007)90IG, 50; IG + SG, 26Standard care, 25Total, 101 (73/28); IG, 50 (35/15); IG + SG, 26 (22/4); CG, 25 (16/9)IG, 29.9; IG + SG, 29.6; CG, 29.9DSM-IV; schizophrenia case notes screened by RAsIG, 9.6; IG + SG, 11.3; CG, 10.3Family advocacy and support agency, Association for Research on Schizophrenia, MilanRCTTreatment compliance; relapse rates, HA rates; GAS; employment rates (baseline, 12 months and 24 months post intervention)24 months post intervention: total, 6/101(5.9); IG, 3/50 (6); IG + SG, 2/26 (8); CG, 1/25 (4)Compliance with standard community care significantly higher at 12 months post intervention in the IG + SG group than in the CG
Chan et al. (2009)83PE, 36Standard care – enhanced, 37Total, 73 (48/25); PE, 36 (26/10); CG, 37 (22/15)PE, 34.2; CG, 36.3DSM-IV; outpatient diagnosis schizophrenia by psychiatristPE, 10.2; CG, 10.5Psychiatric outpatient department of a regional mental health hospital in Hong KongCluster RCTBPRS; ROMI; ITAQ; SES (baseline, post intervention, 6 months and 12 months post intervention)No attritionSignificant improvements over time found for the PE group in BPRS, ROMI and ITAQ scores. Significant group differences were found for BPRS at 6 months, ROMI at post intervention and at 6 months post intervention and the ITAQ at 6 and 12 months post intervention
Chien (2008)94PESG, 34Standard care – enhanced, 34Total, 68; NRPESG, 37.3; CG, 28.8DSM-IV; schizophrenia diagnosis2.5Two psychiatric outpatient clinics, Hong KongCluster RCT

SLOF (baseline, 1 and 12 months post intervention)

Number and duration of HAs (6 months pre intervention, over 9-month intervention period, 12 months post intervention)

12 months post intervention: total, 5/68, (7.4); PESG, 3/34 (8.8); CG, 2/34 (5.9)PESG showed significant improved level of functioning (SLOF) from baseline to 6 months post intervention when compared with the CG
aChien and Chan (2004)80MSG, 32; PE, 33Standard care – enhanced, 31Total, 96 (62/34); MSG, 32 (20/12); PE, 33 (20/13); CG, 31 (22/9)MSG, 32.3; PE, 29.1; CG, 33.8DSM-IV; schizophrenia diagnosisJust over 2 years (range: 6 months–5 years)Two psychiatric outpatient clinics, Hong KongCluster RCT

BPRS; SLOF; (baseline, 1 week and 12 months post intervention)

Number and duration of HAs (pre-intervention, over 6-month intervention period, 12 months post intervention)

12 months post intervention:total, 7/96 (7.3); MSG, 4/32 (12.5); PG, 2/33 (6.1); CG, 1/31 (3.2)MSG participants reported significant reduction in rehospitalisation compared with the PE group and the CG and greater improvement in all three subscales of SLOF (self-maintenance, social functioning and community living skills)
Chien and Chan (2013)98MSG, 45; PE, 45Standard care – enhanced, 45Total, 135 (84/51); MSG, 45 (28/17); PE, 45 (27/18); CG, 45 (29/16)MSG, 24.3; PE, 25.2; CG, 26.2DSM-IV; schizophrenia diagnosisMajority 1–2 years for all three groupsTwo psychiatric outpatient clinics, Hong KongCluster RCT

BPRS; SLOF (baseline, 1 week, 12 and 24 months post intervention)

Number and duration of HAs (9 months pre intervention, 1 week, 12 and 24 months post intervention)

24 months post intervention: total, 7/135 (5.2); MSG, 2/45 (4.4); PG, 3/45 (6.7); CG, 2/45 (4.4)At 12 and 24 months post-intervention time points compared with the CG BPRS score decreased significantly and the SLOF score for the MSG group increased significantly. Scores also decreased at 12 and 24 months post intervention when compared with the PE group. The average length of rehospitalisations was significantly lower in the MSG than the CG at all post-intervention time points
aChien et al. (2006)79MSG, 32; PE, 33Standard care – enhanced, 31Total, 96 (64/32); MSG, 32 (20/12); PE, 33 (22/11); CG, 31 (22/9)MSG, 27.3; PE, 27.8; CG, 28.8DSM-IV; outpatients case note diagnosis schizophreniaAbout 2 years (range 6 months–3 years)Two psychiatric outpatient clinics, Hong KongCluster RCT

BPRS; SLOF; (baseline, 6 and 18 months post intervention)

Number and duration of HAs (6 months pre intervention, 6 and 18 months post intervention)

18 months post intervention: total, 7/96 (7.3); MSG, 2/32 (6.3); PE, 2/33 (6.1); CG, 3/31 (9.7)Readmissions to hospital in the MSG group reduced significantly more than the other two groups from baseline to 18 months post intervention. Level of functioning in the MSG group improved significantly from baseline to 18 months post intervention compared with the other two groups. Patient functioning in the PE group also improved over time and significantly more than the CG
Chien and Lee (2010)97SCMP, 46Standard care – enhanced, 46Total, 92; NRNRDSM-IV; schizophrenia diagnosisNRThree psychiatric outpatient clinics, Hong KongRCT

BPRS; SLOF; (baseline, 1 and 15 months post intervention)

Number and duration of HAs (6 months preceding intervention, 1 and 15 months post intervention)

15 months post intervention: total, 3/92 (3.3); SCMP, 2/46 (4.3); CG, 1/46 (2.2)There were significant differences between the SCMP group and the CG with patients’ functioning and number and length of rehospitalisations at 1 and 15 months post intervention, although patients’ functioning and number and length of rehospitalisations in the SCMP group only significantly improved at the 15 months post-intervention time point
Chien and Lee (2013)103MBPP, 48Standard care – enhanced, 48Total, 96 (53/43)25.8DSM-IV; schizophrenia diagnosisNRThree psychiatric outpatient clinics, Hong KongRCT

BPRS; SLOF; SSQ; ITAQ (baseline, 3 and 18 months post intervention)

Number and duration HAs (6 months preceding intervention, 3 and 18 months post intervention)

18 months post intervention: total, 6/96 (6.3); MBPP, 3/48 (6.3); CG, 3/48 (6.3)There were significant differences between the MBPP group and the CG related to patients’ insight into illness, symptom severity, functioning and number and length of rehospitalisation at 3 and 18 months post intervention. MBPP participants’ symptom severity, illness insight and length of rehospitalisation improved significantly at 3 and 18 months post intervention, but functioning and number of rehospitalisation only significantly improved 18 months post intervention
Chien et al. (2004)104MSG, 24Standard care – enhanced, 24Total, 48 (27/21); MSG, 24 (14/10); CG, 24 (13/11)MSG, 39.9; CG, 36.3DSM-IV; schizophrenia diagnosisApproximately 2 yearsTwo psychiatric outpatient clinicsCluster RCTDuration of HAs (3 months preceding intervention, over the 3-month intervention period and 3 months post intervention)No attritionIn the MSG group there was a significant decrease in the duration of patient rehospitalisation at 3 months post intervention compared with the CG
Chien and Thompson (2013)101FPGP, 35

CG1 standard care – enhanced, 35;

CG2 psychoeducation, 36

Total, 106 (66/40); FPGP, 35 (21/14); CG1, 36 (23/13); CG2, 35 (22/13)FPGP, 26.3; CG1, 28.2; CG2, 27.2DSM-IV; schizophrenia diagnosis2.5 years (range 6 months–6 years)Three psychiatric outpatient clinics, Hong KongRCT

BPRS; SLOF; (baseline, 1 week, 18 and 36 months post intervention)

Number and duration of HAs (6 months preceding intervention, 1 week, 18 and 36 months post intervention)

36 months post intervention: total, 12/106 (11.3); FPGP, 4/35 (11.4); CG1, 3/36 (8.3); CG2, 5/35 (14.3)Functioning improved significantly at 1 week and 18 months post intervention. Rehospitalisation of FPGP patients decreased significantly at the three respective time points in number and duration compared with CG1 and decreased significantly at 1 week and 18 months post intervention when compared with CG2. In the FPGP group there was a significant difference between patients’ SLOF score compared with the PE group and the CG
Chien et al. (2008)84MSG, 38Standard care – enhanced, 38Total, 76 (32/44);MSG, 38 (17/21); CG, 38 (15/23)MSG, 25.3; CG, 25.6DSM-IV; schizophrenia diagnosisMSG, 2.7; CG, 2.6Two psychiatric outpatient clinics, Hong KongRCT

BPRS (baseline, 1 week and 12 months post intervention)

Number and duration of HAs (6 months preceding intervention, 1 week and 12 months post intervention)

No attritionIn the MSG group the duration of patients’ rehospitalisation decreased significantly at 12 months post intervention
Chien and Wong (2007)105PE, 42Standard care – enhanced, 42Total, 84 (51/33)28.8DSM-IV; schizophrenia diagnosis3.6Two psychiatric outpatient clinics, Hong KongRCT

BPRS; SLOF; (baseline, 1 week and 12 months post intervention)

Number and duration of HAs (6 months preceding intervention, 1 week and 12 months post intervention)

12 months post intervention: total, 7/84 (8.3); PE, 3/42 (7.1); CG, 4/42 (9.5)In the PE group number of patients’ rehospitalisation improved significantly at 1 week and 12 months post intervention. However, patients’ functioning and length of rehospitalisation only significantly improved at 12 months post intervention
Gohar et al. (2013)111SCST, 22Non-adapted SCSTTotal, 42 (34/8); SCST, 22 (16/6); CG, 20 (18/2)SCST, 33.0; CG, 31.0DSM-IV SCID I; schizophrenia diagnosisSCST, 11.8; CG, 8.4Outpatient clinic of the psychiatry and addiction hospital of Kasr Al-Ainy hospitals, Cairo university, EgyptRCTPANSS; MSCEIT; TMT Part A and Digit Symbol Substitution Test; the Digit Span Task from the Wechsler Memory Scale; the Proteus Maze Task; (baseline, post intervention)NR – but tables suggest no attritionSCST showed significant improvements in social cognition compared with the CG. On the MSCEIT, the SCST group showed significant improvements on the total score and branches 1 (emotion perception) and 4 (managing emotions)
Guo et al. (2010)109CT, 633Medication, 635Total, 1268 (698/570); CT, 633 (344/289); CG, 635 (354/281)CT, 26.1; CG, 26.4DSM-IV SCID I; schizophrenia/schizophreniform diagnosis rated by investigators or trained staff; PANSS total score < 60CT, 2.1; CG, 2Ten clinical sites in China (six university clinics and four province mental health agencies)RCT

PANSS; ITAQ; GAS; ADL; SF-36 (baseline, 3 and 6 months post intervention)

Rates of treatment discontinuation (assessed every 2 weeks by a RA and monthly by a psychiatrist)

12 months post intervention: total, 524/1268 (41.3); CT, 227/633 (35.9); CG, 338/635 (46.8)Risk of relapse and readmission was lower in the CT group. Change in ITAQ scores was greater in the CT group than the CG. GAS and ADL scores were also greater over time for the CT group. the CT group also scored higher on four domains of the SF-36 (role-physical, general health, vitality and role-emotional)
Habib et al. (2015)71CaCBTp, 21Standard care – medical consultation, 21Total, 42 (25/17); CaCBTp, 21(11/10); CG, 21 (14/7)CaCBTp, 33.5; CG, 30.2DSM-IV-TR; inpatient; schizophrenia diagnosisCaCBTp, 8.8; CG, 8.6Psychiatric inpatient clinic, Lahore, PakistanRCTPANSS; PSYRATS; SAI (baseline, post intervention)NRCaCBTp group demonstrated significantly greater improvement on PANSS positive, negative and general symptoms and PSYRATS hallucinations, delusions and insight post intervention
Koolaee and Etemadi (2009)91BFM, 21; PE, 21Standard care – enhanced, 20Total, 55 (40/15)NRDSM-IV; schizophrenia diagnosis≤ 3 yearsPsychiatric outpatient clinic in Tehran, IranRCT

BPRS (baseline, 3 and 6 months post intervention)

Number and duration of HAS (preceding 3 months, baseline, 3 and 6 months post intervention)

Post intervention: total, 7/62 (11.3); BFM group, 3/21 (14.3); PE, 2/21 (9.5); CG, 2/20 (10)PE and BFM groups exhibited significantly greater reduction in positive symptoms at 3 and 6 months post intervention compared with the CG. PE-positive symptoms reduced significantly from baseline to 6 months post intervention when compared with BFM. Hospitalisation data NR
Kopelowicz et al. (2003)99ST, 45Standard care, 47Total, 92 (62/30); ST, 45 (30/15); CG, 47 (32/15)ST, 37.6; CG, 39.1DSM-IV; schizophrenia/schizoaffective diagnosis; one or more episodes of treatment in an inpatient facility, ≥ 1 week duration in previous 12 monthsNRCommunity mental health centre, Los Angeles, CA, USARCTPANSS; HA rates; ILSS; QOLI; ROMI; MMM + generalisation assessments; SMM + generalisation assessments (baseline, post intervention and 6 months post intervention); medication adherence (monthly)6 months post intervention: total, 8/102 (7.8); ST, 6/45 (13.3); CG, 2/47 (4.3)ST participants showed significantly reduced positive, negative and total symptoms post intervention which were maintained at 6 months post intervention. In the ST group there was also a significant main effect on skill acquisition for medication and symptom management skills. The ST group showed significantly improved level of functioning compared with the CG at post intervention. There was also significantly lower rehospitalisation rates in the ST group from baseline to follow-up compared with the CG
Kopelowicz et al. (2012)117MFG-A, 64; MFG-S, 54Standard care, 60Total, 174 (114/60); MFG-A, 64 (43/21); MFG-S, 53 (36/17); CG, 57 (35/22)MFG-A, 32.6; MFG-S, 29.6; CG, 32.8DSM-IV structured clinical interview; schizophrenia/schizoaffective diagnosisNRTwo community mental health centres, Los Angeles, CA, USARCT

BPRS (baseline, post intervention and 12 months post intervention); medication compliance (baseline, 4 and 8 months post baseline, post intervention, 6 and 12 months post intervention)

HA rates (4 and 8 months post baseline, post intervention, 6 and 12 months post intervention)

12 months post intervention: total, 33/178 (18.4); MFG-A, 10/64 (15.6); MFG-S, 13/54 (24.1); CG, 10/60 (16.7)At post intervention, the MFG-A group demonstrated significantly higher medication adherence than the MFG-S group or the CG. The MFG-A participants had a longer time to first hospitalisation and were less likely to be hospitalised than those in the MFG-S group and the CG
Kulhara et al. (2009)86PE, 38Standard care – enhanced, 38Total, 76 (42/34); PE, 38 (17/21); CG, 38 (25/13)PE, 31.1; CG, 31.6DSM-IV; structured interview; schizophrenia diagnosisPE, 4.7; CG, 5.1Department of psychiatry of a tertiary care hospital in North IndiaRCT

PANSS; WHODAS (baseline, 1, 2, 3, 4, 5, 6 and 7 months post baseline; post intervention)

Relapse (over the 9-month intervention period)

Post intervention: total, 33/76 (43.4); PE, 15/38 (39.5); CG, 18/38 (47.4)There was a significantly greater decline in monthly PANSS scores in the PE group on all three subscales in comparison with the CG. The only patient outcome showing a significant difference from baseline to post intervention was disability level, with the PE, group showing significantly lower levels of disability at post intervention than the CG
Kumar et al. (2010)112HMCT, 8Standard care, 8Total, 16/0; HMCT, 8/0; CG, 8/0HMCT, 31.5; CG, 34.1ICD-10; patient diagnosis paranoid schizophreniaHMCT, 7.6; CG, 6.5Inpatient hospital, central institute of psychiatry, Ranchi, IndiaRCTPANSS (baseline, 2 week post baseline, post intervention)NRThe HMCT group demonstrated a significantly greater reduction in positive symptoms post intervention compared with the CG
Kung et al. (2012)85FP, 9‘Comparison group’ no detailsTotal, 12; FP, 9; CG, 3MFPG, 34.2; CG, 50.6‘Schizophrenic form of disorder’NRPsychiatric outpatient clinicsNon-RCTBPRS; SANS; SLOF; WQOL (baseline, 3 months post baseline, post intervention, 3 months post intervention)No attritionIn the MFPG group, BPRS and SANS scores showed significant improvement at post intervention and 3 months post intervention. The SLOF score was in the opposite direction than expected but consistent with the previous within group scores recorded at baseline, post-intervention and 3 months post-intervention
Lak et al. (2010)106CBCSM + SGT, 35; CBCSM, 35‘Placebo’ education and rehabilitation programme, 36Total, 106 (53/53); CBCSM + SGT, 35 (18/17); CBCSM, 35 (17/18); CG, 36 (18/18)CBCSM + SGT, 38.3; CBCSM, 44.5; CG, 43.2ICD-10; schizophrenia diagnosis, free-from positive symptoms as indicated by BPRS score > 72CBCSM + SGT, 15.6; CBCSM, 18.3; CG, 18.9NRRCTBPRS; GAF; VSSS; ASSEI; PWI (baseline, post intervention, 3 and 6 months post intervention)6 months post intervention: total, 10/106 (9.4); CBCSM + SGT, 4/35 (11.4); CBCSM, 6/35 (17.1); CG, 0/36 (0)Post intervention, the CBCSM + SGT group and the CBCSM group scored significantly higher than the CG in social skills. At 6 months post intervention, social skills of the CBCSM + SGT group were better than the CBCSM group and the CG
Li and Arthur (2005)96FE, 46Standard care, 55Total, 101 (43/58); FE, 46 (18/28); CG, 55 (25/30)NRCCMD-II-R; inpatient diagnosis schizophreniaNRNon-acute inpatient hospital, Beijing, ChinaCluster RCTBPRS; GAS; KASI; NOSIE; relapse rates; medication compliance (baseline, post intervention, 3 and 9 months post intervention)9 months post intervention: total, 12/101 (11.9); FE, 3/46 (6.5); CG, 9/55 (16.4)FE group showed significantly greater improvements in symptom severity, knowledge and overall functioning at 9 months post intervention compared with the CG
Li et al. (2015)107CBT, 96Supportive therapy (TE), 96Total, 192 (72/120); CBT, 96 (32/64); CG, 96 (40/56)CBT, 29.3; CG, 33.4SCID; DSM-IV; Axis I schizophrenia by research psychiatristsCBT, 7.6; CG, 8.8Three specialised psychiatric hospitals, BeijingCluster RCTPANSS; SAI; PSP (baseline, 12, 24, 36, 60 and 84 weeks post baseline)84 weeks post baseline: total, 25/192 (14.6); CBT, 11/96 (11.5); CG, 14/96 (14.6)Both groups had a significant decrease in all PANSS symptoms, SAI insight and PSP social functioning post intervention (24 weeks), which were maintained up to 84 weeks post baseline. Compared with the CG, CBT showed significantly greater reductions in PANSS total and positive symptoms and PSP functioning scores from 36 weeks post baseline
Lin et al. (2013)88IMR, 48Standard care, 49Total, 97 (62/35); IMR, 48 (30/18); CG, 49 (32/17)IMR, 35.3; CG, 35.2DSM-IV; schizophrenia/schizoaffective diagnosisIMR, 11.8; CG, 11.2Acute inpatient ward in two hospitals in TaiwanRCTBPRS; KI; DAI-30; SAI-E (baseline, post intervention and 1 month post intervention)1 month post intervention: total, 14/97 (14.4); IMR, 4/48 (8.3); CG, 10/49 (20.4)The IMR group showed significantly greater improvements at post intervention and 1 month post intervention than the CG in BPRS negative symptoms, insight, illness management knowledge and attitudes towards medication
Lin et al. (2013)116IMR, 26N/ATotal: IMR, 26 (18/8)36.38DSM-IV; schizophrenia/schizoaffective diagnosisNRSix psychiatric acute wards at a psychiatric hospital in the department of psychiatry, TaiwanNon-RCTBPRS; KFI; DAI-30; SAI-E (baseline, post intervention)NRParticipants improved in each psychopathology domain post intervention; however, only the change in the affective domain was significant
Mann and Chong (2004)113SCP, 25Education programme, 25Total, 50 (38/12)44.4DSM-IV; schizophrenia diagnosis with active positive psychotic symptoms ≥ 1 year assessed by psychiatristAverage length of stay in hospital: 26.2 months (range 12–68 months)Inpatient psychiatric hospital, Hong KongRCTPANSS; LSP (baseline, post intervention and 1 month post intervention)NRPost-intervention, there was a significant improvement in PANSS scores for SCP and CG. However, this returned back to baseline level at 1 month post intervention
bMausbach et al. (2008)81PEDAL, 21CG1 FAST (non-adapted PEDAL), 15; CG2 support group (TE), 23Total, 59 (35/24); PEDAL, 21 (11/10); CG1, 15 (10/5); CG2, 23 (14/9)PEDAL, 50.7; CG1, 47.4; CG2, 47.3DSM-IV; diagnosis of schizophrenia, schizoaffective or psychotic mood disorderPEDAL, 23.5; CG1, 24.5; CG2, 23.8Board and care facilities, San Diego country and mental health clinics near the USA–Mexico borderBlock RCTPANSS; UPSA; SSPA; MMAA; QWB (baseline, post intervention)Post intervention: total, 10/59 (16.9); PEDAL, 3/21 (14.3); CG1, 2/15 (13.3); CG2, 5/23 (21.7)PEDAL group showed a significant improvement on the UPSA compared with those in CG1 and CG2. The PEDAL group had significantly higher SSPA scores at post intervention compared with CG1, but not CG2. The PEDAL group also made significantly fewer medication errors at post intervention than CG2
Naeem et al. (2015)92CaCBTp, 59Standard care, 57Total, 116 (70/46); CaCBTp, 57 (39/18); CG, 59 (31/28)CaCBTp, 31.7; CG, 31.1ICD-10 RDC; diagnosis of schizophrenia or related disorderCaCBTp, 4.7; CG, 5.8Psychiatric outpatient clinics, Karachi, PakistanRCTPANSS; PSYRATS; SAI (baseline, post intervention)Post intervention: total, 14/116 (12.1); CaCBT, 6/59 (10.1); CG, 8/57 (14)At post intervention the CaCBTp group showed significantly greater improvements compared with the CG, in PANSS positive and negative symptoms and general psychopathology, PSYRATS delusions and hallucinations and insight
bPatterson et al. (2005)82PEDAL, 21Support group, (TE) 8Total, 29 (14/15); PEDAL, 21 (11/10); CG, 8 (3/5)PEDAL, 46.8; CG, 57.3DSM-IV; case note diagnosis of schizophrenia/schizoaffective disorderAge of illness onset (years): PEDAL, 28.3; SG, 43.5Psychiatric clinics, San Diego, CA, USACluster RCTPANSS; UPSA; MMAA; SSPA; QWB (baseline, post intervention, 6 and 12 months post intervention)12 months post intervention: total, 5/21 (23.8); PEDAL, 5/21 (23.8); CG, no attritionAt 6 months post intervention the PEDAL had a significantly greater UPSA score than the CG. However, no significant differences were found between the groups at 6 and 12 months post intervention. At 12 months post intervention, the PEDAL group performed significantly better than the CG. The CG also had significantly lower PANSS ratings than the PEDAL group at 12 months post intervention
Ran et al. (2003)100FIG, 132CG1 medication treatment, 110; CG2 no intervention, 115Total, 326 (128/198); FIG, 126 (44/82); CG1, 103 (48/55); CG2, 97 (36/61)FIG, 43.5; CG1, 42.4; CG2, 44.8ICD-10 and CCMD-II-R schizophrenia diagnosisFIG, 11.6; CG1, 10.6; CG2, 12.3NRCluster RCTPSE; GPISS; SDSS; medication compliance; relapse rate (baseline, post intervention)Post intervention: total, 22/326 (6.7); FIG, 1/127 (0.8): CG1, 2/105 (1.9); CG2, 18/115 (15.7)At post intervention, FIG treatment compliance was significantly higher than that in CG1 and CG2. There was no significant difference of clinical outcomes between FIG group and CG1, whereas the percentage of full recovery and significant improvement in FIG and CG1 was significantly higher than that in CG2. The relapse rate in FIG was significantly lower than CG1
Razali et al. (2000)93CMFT, 80BFT, 86NRNRDSM-IV; diagnosis schizophreniaCMFT, 13.7; CG, 14.2Outpatient hospital, University Hospital (USM) Kota Bharu, West MalaysiaRCTBPRS; GAF; SBS; relapse rates; HA rates; medication compliance (baseline, 6 and 12 months post baseline)6 and 12 months post baseline: total, 23/166 (13.9); CMFT, 6/80 (7.5); CG, 17/86 (19.8)At 12 months post baseline the CMFT group showed significant improvements in all variables compared with the CG
Shin and Lukens (2002)118PE, 24Supportive therapy (TE), 24Total, 48 (20/28); PE, 24 (7/17); CG, 24 (13/11)PE, 39.5; CG, 34.7DSM-IV; diagnosis of schizophrenia, schizoaffective, or schizophreniform disorder rated by psychiatrist

Number of hospitalisations: PE, 2.7; CG, 1.2

Time since last hospitalisation (months): PE, 7.2; CG, 12.7

Outpatient mental health clinic, Queens, New York, NYRCTBPRS; SDS (baseline, post intervention)NR (tables suggest no attrition)At post intervention, the PE, group demonstrated significantly reduced symptom severity and perception of stigma in comparison with the CG
So et al. (2015)110MCTd, 23Standard care – medication consultations, 21Total, 44 (24/20); MCTd, 23 (12/11); CG, 21 (12/9)MCTd, 32.4; CG, 35.6Case note diagnosis schizophrenia, four or more PANSS delusions itemsNumber of hospitalisations: MCTd, 1.6; CG, 0.9Outpatient clinic, Hong KongRCTPANSS; PSYRATS (baseline, post intervention and 1 month post intervention); WAIS (baseline or pre intervention only)1 month post intervention: total, 18/44 (40.9) MCTd, 10/23 (43.5); CG, 8/21 (38.1)At post intervention there was a large effect size of improvement for the MCTd group’s PANSS positive scores, PANSS delusions score, PSYRATS delusions and PSYRATS delusional conviction
Valencia et al. (2007)120PSST, 49Standard care – medication consultations, 49Total, 82 (64/18); PSST, 43 (31/12); CG, 39 (33/6)PSST, 29.7; CG, 30.1DSM-IV and CIDI schizophrenia diagnosis with clinically stable psychotic symptoms (≥ 60 PANSS score)Age of illness onset (years): PSST, 21.3; CG, 21.2Psychiatric outpatient hospital, MexicoRCTPANSS; PSFS; GAF (baseline, post intervention); relapse rates; HA rates; medication compliance; therapeutic adherence (over 12-month intervention period)Post intervention: total ,16/98 (16.3) PSST, 6/49 (12.2); CG, 10/49 (20.4)At post intervention, the PSST group showed significantly improved symptomatology scores on total score, positive and negative symptoms and GPS compared with the CG with large effect sizes for both groups. Significant improvements were also observed in the PSST group for all areas of psychosocial functioning and in the GPFS compared with the CG, and also with global functioning. During the intervention the PSST group had a significantly higher level of compliance with medication, therapeutic adherence and a significantly lower relapse rate than the CG
Valencia et al. (2010)119PSST, 54Standard care – medication consultations, 53Total, 83 (60/23); PSST, 47 (34/13); CG, 36 (26/10)PSST, 29.9; CG, 29.5DSM-IV and CIDI schizophrenia diagnosisAge of illness onset (years) PSST, 22.4; CG, 21.1National institute of psychiatry outpatient clinic, Mexico CityRCTPANSS; GAF (baseline, post intervention); relapse rates; HA rates; adherence to medication (over 12-month intervention period)Post intervention: total, 24/108 (22.2); PSST, 7/54 (13); CG, 17/54 (31.5)At post intervention, the PSST group exhibited significantly improved symptomatology, adherence to medication, attendance at appointments, social functioning, relapse and rehospitalisation rates
Wahass and Kent (1997)76MPI, 3Standard care – medication consultation, 3Total, 6 (6/0); MPI, 3 (3/0); CG, 3 (3/0)MPI, 31.3; CG, 34.0ICD-10; schizophrenia diagnosisExperiencing persistent auditory hallucinations for at least 4 yearsNRRCTSAHI; 10-cm VAS to measure hallucination severity; two VAS to measure anxiety and depression in response to voices (baseline, post intervention, 3 months post intervention)NR – tables suggest no attritionSymptom ratings improved for two participants in the MPI group, but there were no changes in the third participant. The third patient also reported that the loudness of his voices increased over time
Wang et al. (2013)102SCIT, 22Standard care – medication consultations, 17Total, 39 (20/19); SCIT, 22 (12/10); CG, 17 (8/9)SCIT, 43.9; CG, 40.9DSM-IV; schizophrenia diagnosisNRNRRCTPANSS; WAIS; PSP; FEIT; computerised version of the Eyes Task; Attributional Style Questionnaire (baseline, 6 months post intervention)6 months post intervention: total, 4/43 (9.3); SCIT, 0/22 (0); CG, 4/21 (19)The SCIT group showed a significant improvement in emotion perception, theory of mind, attributional style and social functioning compared with the CG
Weng et al. (2005)108MRP, 62Standard care – enhanced, 62Total, 124; MRP, NR; CG, NRNRDSM-III-R; schizophrenia diagnosisNRAnding psychiatric hospital inpatient ward, BeijingRCTBPRS; NOSIE; SDSS; relapse and HA rates (every 2 weeks during intervention, monthly post intervention up to 12 months post intervention)12 months post intervention: total, 2/124 (1.6); MRP, 1/62 (1.61); CG, 1/62 (1.61)BPRS, NOSIE, SDSS relapse and rehospitalisation rates improved significantly in the MRP group from baseline to post intervention and from post intervention to 12 months post intervention
Xiang et al. (1994)114PFI, 36Medication treatment, 41Total, 77; PFI, 36; CG, 41PFI, 40.5; CG, 41.2Schizophrenia and affective psychoses15.3Three rural townships of Xinjin county, ChinaRCTPSE; SDSS; medication compliance rates (baseline, post intervention)NRMedication compliance was significantly higher in the PFI group than in the CG post intervention. In addition, the total rate of improvement in clinical state and level of social functioning was significantly higher in the PFI group than in the CG post intervention
Xiong et al. (1994)89FIG, 34Standard care – medication treatment, 29Total, 63 (43/20)31DSM-III-R; schizophrenia assessed on admission7.5Psychiatric outpatient clinic and home visitsRCTBPRS; SAPS; SANS; GAF; SDSS; number and duration of HAs; relapse rates; medication compliance (baseline, 6, 12 and 18 months post intervention)18 months post intervention: total, 4/63 (6.3); FIG, 2/34 (5.9); CG, 2/29 (6.9)Duration of rehospitalisation significantly shorter for FIG group at 12 and 18 months, and fewer relapsed at 12 months than the CG. BPRS, GAF and SDSS scores at 12 months and SAPS, BPRS, GAF and SDSS scores at 18 months showed significantly greater improvements in FIG group
cZhang and Heqin (1993)77FE, 2076Standard care, 1016Total, 3082 (1821/1261); FE, 2076 (1239/837); CG, 1016 (582/424)FE, 40.3; CG, 40.8CCMD-II; schizophrenia diagnosisFE, 15.1; CG, 15.5NRCluster RCTStudy-specific questionnaire; symptoms, recovery, relapse and duration of hospitalisation; WHO-DAS (baseline, 6 and 12 months post intervention)NRAt post intervention, participants in the FE group showed a higher rate of recovery or stabilisation of condition; a greater reduction in exacerbation of both positive and negative symptoms, relapse rates, number institutionalised, duration of hospitalisation, plus total and factor score on the WHO-DAS
Zhang et al. (1994)87FIG, 42Standard care, 41NRFIG, 23.5; CG, 24.1Chinese Medical Association (1985): first admission patients with a diagnosis of schizophreniaNRPsychiatric outpatient clinic and family homeRCTBPRS; GAS; HA rates (baseline; post intervention; 3, 6, 9, 12, 15 and 18 months post intervention)18 months post intervention: total, 5/83 (6); FIG, 3/42 (7.1); CG, 2/41 (4.9)At 18 months post intervention, participants in the FIG group who were not readmitted had less severe psychiatric functioning and higher overall functioning compared with members of the CG who were not readmitted. The proportion of patients who were readmitted to hospital was significantly greater among those in the CG in comparison with participants who received the FIG
cZhang et al. (1998)78FE, 682Standard care, 355Total, 1037 (642/395); FE, 682 (420/262); CG, 355 (222/133)FE, 38.3; CG, 39.0CCMD-2; schizophrenia diagnosisFE, 7.3; CG, 7.7NRCluster RCTStudy-specific questionnaire to assess severity of the illness and symptoms, relapse, duration of HAs; WHO-DAS (baseline, 6, 12 and 24 months post baseline)24 months post baseline: total, 236/1284 (18.4); FE, 169/851 (19.9); CG, 67/433 (15.5)At 24 months post baseline, those in the FE group showed a higher rate of recovery and stabilisation of the condition; a lower rate of exacerbation of symptoms and a reduction in annual relapse rates and annual times institutionalised in comparison with the CG
Zimmer et al. (2007)95IPT, 23Standard care – medication consultation, 43Total, 56 (42/14); IPT, 20 (17/3); CG, 36 (25/11)IPT, 36.1; CG, 39.3‘Schizophrenia outpatient database’IPT, 15.3; CG, 17.1Schizophrenia outpatient programme of the Hospital de Clínicas de Porto AlegreRCTMMSE; GAF; SOFAS; WHOQOL-BREF; SAS (baseline, post intervention)Total, 4/56 (7.1); NR by groupAt post intervention, the IPT group demonstrated significantly improved scores on cognition in the domains of spatiotemporal orientation, memory, social adjustment, leisure/social life, family relations, overall functioning, social occupational functioning and quality of life in the psychological domain

ADL, Activities of Daily Living Scale; ASSEI, Adult Sources of Self-Esteem Inventory; BFT, behaviour family therapy; BPRS, Brief Psychiatric Rating Scale; CaCBTp, culturally adapted cognitive–behavioural therapy for psychosis; CBCSM, Chinese basic conversation skill module; CCMD-II-R, Chinese Classification of Mental Disorders, Second Edition – Revised; CG, comparison group; CG1, comparison group 1; CG2, comparison group 2; CIDI, Composite International Diagnostic Interview; CMFT, culturally modified family therapy; CT, combined treatment; DAI-30, Drug Attitude Inventory-30; F, female; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, Third Edition – Revised; DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision; FAST, functional adaptation skills training; FE, family education programme; FEIT, face emotion identification task; FIG, psychoeducational family intervention group; FP, family psychoeducation; FPGP, family led peer support group programme; GAF, Global Assessment of Functioning Scale; GAS, Global Assessment Scale; GPISS, General Psychiatric Interview Schedule and Summary Form; HA, hospital admission; HMCT, Hindi meta-cognitive training; HoNAS, Health of the Nation Outcome Scale; ICD-10 RDC, International Classification of Diseases, 10th edition, Research Diagnostic Criteria; IG, information group programme; IG + SG, information group programme and additional support programme; KFI, Knowledge of Illness Scale; ILSS, Independent Living Skills Survey; ITAQ, Insight and Treatment Attitudes Questionnaire; KI, Knowledge of Illness-Management (KIM) Scale; LSP, Life Skill Profile; M, male; MBPP, mindfulness-based psychoeducation programme; MFG-A, adherence-focused multiple-family group therapy; MFG-S, standard multiple-family group therapy; MFGT, multiple-family group intervention; MFPG, family psychoeducation programme; MMAA, Medication Management Ability Assessment; MMM, Medication Management Module; MMSE, Mini Mental State Examination; MPI, modified psychological intervention; MSCEIT, Mayer–Salovey–Caruso Emotional Intelligence Test 2.0; MSG, mutual support group family intervention; N/A, not applicable; NOSIE, Nurses’ Observation Scale; NR, not reported; PE, psychoeducation programme; PEDAL, Programa de Entrenamiento para el Desarrollo de Aptitudes para Latinos; PESG, psychoeducation and mutual support group programme; PFI, psychoeducational family intervention; PSE, Present State Examination; PSFS, Psychosocial Functioning Scale; PSST, psychosocial skills training; PSYRATS, Psychotic Symptom Rating Scales; PWI, Personal Wellbeing Index; QOL, Quality of Life Scale; QOLI, Quality of Life Interview; QWB, Quality of Well-Being Scale; ROMI, The Rating of Medication Influences; SAHI, Structured Auditory Hallucinations Interview; SAI, Schedule for Assessment of Insight; SAI-E, Schedule for Assessment of Insight – Expanded Version (including treatment adherence); SANS, Scale for Assessment of Negative Symptoms; SAPS, Scale for Assessment of Positive Symptoms; SBS, Social Behaviour Schedule; SAS, Social Adjustment Scale; SCID I, Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders I; SCIT, social cognition and interaction training; SCMP, schizophrenia care management programme; SCP, symptoms coping programme; SCST, social cognitive skills training; SDS, Stigma-Devaluation Scale; SDSS, Social Disability Screening Schedule; SES, The General Perceived Self-Efficacy Scale; SF-36, Short Form questionnaire-36 items; SG, support group; SLOF, Specific Level of Functioning Scale; SMM, Symptom Management Module; SOFAS, Social and Occupational Assessment Scale; SSPA, Social Skills Performance Assessment; SSQ, Social Support Questionnaire; ST, skills training; TE, time equivalent; TMT, Trail Making Test; UPSA, UCSD Performance-Based Skills Assessment; USM, Universiti Sains Malaysia; VAS, visual analogue scale; VSSS, Vocational Social Skill Assessment Scale; WAIS, Wechsler Adult Intelligence Scale; WHODAS, World Health Organization Psychiatric Disability Assessment Schedule; WHOQOL-BREF, World Health Organization Brief Quality of Life Assessment Instrument; WQOL, Wisconsin Quality of Life Index.

a

Same sample: Chien et al. (2006)79 reports 18-month follow-up data for participants in Chien and Chan (2004).80

b

Same sample: Mausbach et al. (2008)81 uses same participants as Patterson et al. (2005)82 in addition to participants from a second wave of recruitment (SG n = 15; FAST n = 15).

c

Same sample: Zhang et al. (1998)78 reports 24-month follow-up for subsample of participants (2/5 catchment areas) in Zhang and Hequin (1993).77

Note

Bold text = included in meta-analysis on symptoms.

Copyright © Queen’s Printer and Controller of HMSO 2018. This work was produced by Edge et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.
Bookshelf ID: NBK525384

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (126M)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...